ArticleVaccines2023

An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line.

Stefan Hirschberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.